Nurix Therapeutics, Inc.NRIXNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Above historical average.
Left:
||||
Price-to-book ratio
Latest
2.72
↑ 464% above average
Average (7y)
-0.75
Historical baseline
Range
High:3.61
Low:-12.79
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | 2.72 | -3.4% |
| 2024 | 2.82 | +67.0% |
| 2023 | 1.69 | -15.0% |
| 2022 | 1.98 | -45.1% |
| 2021 | 3.61 | +56.9% |
| 2020 | 2.30 | +118.0% |
| 2019 | -12.79 | -54.0% |
| 2018 | -8.31 | - |